THQM Stock Overview
Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria.
Tchaikapharma High Quality Medicines AD Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||лв17.00|
|52 Week High||лв17.20|
|52 Week Low||лв14.94|
|1 Month Change||0.59%|
|3 Month Change||1.19%|
|1 Year Change||13.07%|
|3 Year Change||35.34%|
|5 Year Change||144.54%|
|Change since IPO||614.45%|
Recent News & Updates
|THQM||BG Pharmaceuticals||BG Market|
Return vs Industry: THQM exceeded the BG Pharmaceuticals industry which returned 3.5% over the past year.
Return vs Market: THQM exceeded the BG Market which returned 11.4% over the past year.
|THQM Average Weekly Movement||n/a|
|Pharmaceuticals Industry Average Movement||5.2%|
|Market Average Movement||3.9%|
|10% most volatile stocks in BG Market||6.7%|
|10% least volatile stocks in BG Market||2.1%|
Stable Share Price: Insufficient data to determine THQM's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine THQM's volatility change over the past year.
About the Company
Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria. The company offers anaesthetic, anti-inflammatory and anti-rheumatic, antibiotic, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. It also provides nutritional supplements.
Tchaikapharma High Quality Medicines AD Fundamentals Summary
|THQM fundamental statistics|
Is THQM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|THQM income statement (TTM)|
|Cost of Revenue||лв5.47m|
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
|Earnings per share (EPS)||0.047|
|Net Profit Margin||8.44%|
How did THQM perform over the long term?See historical performance and comparison